Compound Detail
CHEMBL1200470
ESOMEPRAZOLE SODIUM 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL1200470 |
| Name | ESOMEPRAZOLE SODIUM |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | RYXPMWYHEBGTRV-JIDHJSLPSA-N |
| Therapeutic | ✓ Yes |
| Parent Compound | CHEMBL1201320 |
| Active Moiety | CHEMBL1201400 |
0
Targets
0
Activities
0
Assay Types
0
PK Parameters
1
Publications
4
Known Names
3
Indications
1
Mechanisms
Molecular Properties
345.4
MW (Da)
2.90
ALogP
5
HBA
1
HBD
83.1
PSA (Ų)
0.72
QED
0
Ro5 Violations
5
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 2005 |
| Availability | Prescription |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Potassium-transporting ATPase inhibitor | INHIBITOR | Potassium-transporting ATPase | ✓ | ✓ |
Indications
Duodenal Ulcer Gastroesophageal Reflux Peptic Ulcer
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 28512024 | 10.1016/j.bmcl.2017.05.010 | Cytosolic endo-beta-N-acetylglucosaminidase | 1 |
Data from ChEMBL 36 via Core Engine